Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Carbidopa
Therapeutic Area : Neurology
Study Phase : Phase IV
Sponsor : Amneal Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Carbidopa is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Parkinson Disease.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
January 09, 2025
Lead Product(s) : Carbidopa
Therapeutic Area : Neurology
Highest Development Status : Phase IV
Sponsor : Amneal Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Carbidopa
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
A TQT Study to Evaluate the Electrocardiographic Effects of Carbidopa in Healthy Subjects
Details : Carbidopa is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
December 07, 2023
Lead Product(s) : Carbidopa
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable